We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Congressional Pressure Mounts on Mylan Despite Cost-cutting Measures
Congressional Pressure Mounts on Mylan Despite Cost-cutting Measures
Despite Mylan’s efforts to quell criticism, U.S. lawmakers continue to press the company and the FDA for greater transparency on the cost of the company’s EpiPen epinephrine auto-injector.